Role of Tyrosine Kinase Syk in Thrombus Stabilisation at High Shear

por Perrella, Gina, Montague, Samantha J., Brown, Helena C., Garcia Quintanilla, Lourdes, Slater, Alexandre, Stegner, David, Thomas, Mark, Heemskerk, Johan W. M., Watson, Steve P.
Publicado 2022

The Btk inhibitor AB‐95‐LH34 potently inhibits atherosclerotic plaque–induced thrombus formation and platelet procoagulant activity

por Smith, Christopher W., Harbi, Maan H., Garcia‐Quintanilla, Lourdes, Rookes, Kieran, Brown, Helena, Poulter, Natalie S., Watson, Steve P., Nicolson, Phillip L. R., Thomas, Mark R.
Publicado 2022

Antiprothrombin antibodies induce platelet activation: A possible explanation for anti‐FXa therapy failure in patients with antiphospholipid syndrome?

por Chayoua, Walid, Nicolson, Phillip L. R., Meijers, Joost C. M., Kardeby, Caroline, Garcia‐Quintanilla, Lourdes, Devreese, Katrien M. J., de Laat, Bas, Watson, Stephen P., de Groot, Philip G.
Publicado 2021

Endogenous topoisomerase II-mediated DNA breaks drive thymic cancer predisposition linked to ATM deficiency

por Álvarez-Quilón, Alejandro, Terrón-Bautista, José, Delgado-Sainz, Irene, Serrano-Benítez, Almudena, Romero-Granados, Rocío, Martínez-García, Pedro Manuel, Jimeno-González, Silvia, Bernal-Lozano, Cristina, Quintero, Cristina, García-Quintanilla, Lourdes, Cortés-Ledesma, Felipe
Publicado 2020

Low-dose Btk inhibitors selectively block platelet activation by CLEC-2

por Nicolson, Phillip L.R., Nock, Sophie H., Hinds, Joshua, Garcia-Quintanilla, Lourdes, Smith, Christopher W., Campos, Joana, Brill, Alexander, Pike, Jeremy A., Khan, Abdullah O., Poulter, Natalie S., Kavanagh, Deidre M., Watson, Stephanie, Watson, Callum N., Clifford, Hayley, Huissoon, Aarnoud P., Pollitt, Alice Y., Eble, Johannes A., Pratt, Guy, Watson, Steve P., Hughes, Craig E.
Publicado 2020